FDA OKs Warner Chilcott's Atelvia for postmenopausal osteoporosis

10/11/2010 | Reuters

The FDA has approved Atelvia, Warner Chilcott's treatment for osteoporosis in postmenopausal women. The delayed-release tablet belongs to the Actonel family of bone drugs that Warner Chilcott purchased last year from Procter & Gamble.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR